However, in SSc, the balance between pro- and anti-apoptotic proteins is disrupted, leading to an increase in the activity of pro-apoptotic pore-forming proteins, such as BAX, and their inhibitors, such as BCL2 and BCL2-XL [88]. This evidence concerns the gene BCL2 and systemic sclerosis.